Acamprosate and naltrexone as a combined therapy for alcohol and benzodiazepine dependence

被引：0
|
作者：
Gahr, M. [1 ]
Schoenfeldt-Lecuona, C. [1 ]
机构：
[1] Univ Ulm Klinikum, Klin Psychiat & Psychotherapie 3, D-89075 Ulm, Germany
来源：
NERVENHEILKUNDE | 2013年 / 32卷 / 1-2期
关键词：
Addiction; abstinence; craving; relapse prevention; DOUBLE-BLIND; NALMEFENE; SAFETY; PHARMACOLOGY; DISULFIRAM; EFFICACY; RECEPTOR; SINGLE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Acamprosate and naltrexone are established strategies for pharmacologic relapse prevention in patients with alcohol dependence. Regarding pharmacodynamic and -kinetic considerations the combination of both agents for this indication is a reasonable treatment option that has been described to be safe and effective in clinical studies. However, this combination is uncommon in clinical practice. We report the case of a patient with severe alcohol- and benzodiazepine dependence who achieved her longest interval of abstinence under combined treatment with acamprosate and naltrexone since the development of her addiction.
引用
收藏
页码：54 / 57
页数：4
相关论文
共 50 条
  • [1] Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy
    Gahr, M.
    Koelle, M. A.
    Schoenfeldt-Lecuona, C.
    [J]. NERVENARZT, 2013, 84 (05): : 584 - 589
  • [2] DISULFIRAM, NALTREXONE AND ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE
    Alho, H.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [3] Rationale for combining acamprosate and naltrexone for treating alcohol dependence
    Mason, BJ
    [J]. JOURNAL OF STUDIES ON ALCOHOL, 2005, : 148 - 156
  • [4] Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2169 - 2173
  • [5] Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence
    Littleton, J
    Zieglgänsberger, W
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2003, 12 : S3 - S11
  • [6] Clinical efficacy, possibilities and limitations of acamprosate and naltrexone for treating alcohol dependence
    Chick, J
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 225S - 225S
  • [7] Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:: a systematic review
    Carmen, B
    Angeles, M
    Ana, M
    María, AJ
    [J]. ADDICTION, 2004, 99 (07) : 811 - 828
  • [8] Acamprosate and Naltrexone for Alcohol Dependence: Results From Cochrane Reviews.
    Roesner, S.
    Soyka, M.
    Ridinger, M.
    [J]. SUBSTANCE ABUSE, 2013, 34 (03) : 325 - 326
  • [9] Naltrexone versus acamprosate for alcohol dependence in Australia: A randomised controlled trial
    Morley, Kirsten
    Teesson, Maree
    Reid, Sophie
    Sannibale, Claudia
    Thomson, Clare
    Phung, Nghi
    Weltman, Martin
    Bell, James
    Richardson, Kylie
    Haber, Paul
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (09) : 47A - 47A
  • [10] PHARMACOGENOMICS OF ACAMPROSATE AND NALTREXONE THERAPY RESPONSE IN ALCOHOL USE DISORDER (AUD)
    Zhu, X.
    Liu, D.
    Gao, H.
    Ho, M.
    Nguyen, T.
    Coombes, B.
    Biernacka, J.
    Karpyak, V.
    Weinshilboum, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S61 - S61
12345